Company / Operating Cash Flow
Outset Medical, Inc. Operating Cash Flow History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$131.4M
FY2025
5-year range
-$145.7M / -$70.3M
FY2021-FY2025
Trend
+9.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow returned to growth in FY2025 after 4 years of decline, reaching -$131M.
Based on SEC 10-K filings.
-$131M in FY2025.
Remained stable around -$131M over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow increased 9.9% year-over-year.
- Peak operating cash flow was recorded in FY2020.
- Lowest operating cash flow in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -0.88 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$131.4M | +9.9% |
| FY2024 | -$145.7M | -11.9% |
| FY2023 | -$130.3M | -31.6% |
| FY2022 | -$99.0M | -40.9% |
| FY2021 | -$70.3M | -51.4% |
| FY2020 | -$46.4M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026